derived T cells cells
engineered T cells
applicable T cells
genetic engineering of T
endogenous T cell receptor
effectiveness of adoptive T cell therapies
broader applicability of adoptive T cell therapy
unlimited availability of induced pluripotent stem cells
novel stem cell genetic engineering strategies
applicability of CARTiPSC
translational application of CARTiPSC
CAR-engineered TiPSCs
order
HLA antigens
HLA-barriers
Generation of safe
novel CD38
proposal
broader use
specific target
Chimeric Antigen Receptors
HLA-independent manner
safe cellular products
broad application
efficient strategy
functional potential of TiPSC
investigation of new strategies
drug-regulated expression of CD38CAR
feasibility
targeted knockout
specificity
TCR
CARs
concept study
Cas9 system
effector function
foundation
Multiple Myeloma
cancer
tumor toxicity
proof
CRISPR
rapid access
current approaches
applicant
persistence
progress
histocompatibility limitations
clinical settings
technology
success
addition